RNA 3'-terminal phosphate cyclase has been partially purified from HeLa cells. In the presence of ATP and Mg2', cyclase preparations catalyze conversion of RNA 3'-terminal phosphate to the 2',3'-cyclic phosphodiester. The mechanism of 3Y-phosphate cyclization was studied with oligoribonucleotides containing terminal 2'-deoxy-or 2'-0-methylribose. Incubation of these substrates with cyclase and ATP results in formation of the corresponding activated 3'-terminal structures, 4N(3')pp(5')A and Nm(3')pp(5')A. It is proposed that an intermediate step in cyclization is transfer of the adenylyl group from ATP to the 3' phosphate of RNA.
in elimination of AMP and formation of the cyclic phosphodiester. Cyclase preparations can be covalently labeled with [a-32P]ATP, suggesting that an earlier step in the cyclization reaction involves formation of an adenylylated enzyme intermediate.
RNA 3'-terminal phosphate cyclase, an enzyme that catalyzes conversion of a 3'-phosphate group to the 2',3'-cyclic phosphodiester at the 3' end of RNA, has been identified previously in extract of HeLa cells (1) . Although the exact function of this enzyme remains unknown, it is likely that the cyclase plays a role in RNA splicing. For example, two distinct RNA ligases involved in tRNA processing in plant (2) (3) (4) (5) (6) (7) (8) and animal (1, 9, 10) cell extracts both apparently require substrates with 2',3'-cyclic phosphate ends (1) (2) (3) (4) (6) (7) (8) (9) . In the case of yeast, it has been demonstrated that cleavage of tRNA precursors by purified splicing endonuclease generates tRNA 5' halves with cyclic phosphodiester termini (11) . The 5'-half molecules that accumulate during pre-tRNA processing in HeLa cell extract also contain 2',3'-cyclic phosphate termini (9) . However, it is not known whether they also are made by a splicing endonuclease or secondarily by the action of the RNA 3'-terminal phosphate cyclase. Since no processes other than RNA ligation are presently known to require a terminal cyclic phosphate (for reviews, see refs. 12 and 13), it is tempting to speculate that a role of cyclase is to generate and/or maintain cyclic structures at the ends of ligation substrates. The presence of cyclase activity in extracts of Xenopus oocyte nuclei is consistent with this possibility (1) .
Here we report on partial purification of the RNA 3'-terminal phosphate cyclase from HeLa cells. We demonstrate that transfer of the adenylyl group from ATP to the 3'-phosphate of RNA, resulting in formation of an N(3')pp(5')A structure, is an (14) ; for [5,_32P] pCmp, a mixture of pCm and Cmp, obtained by limited digestion of pC'p with alkaline phosphatase followed by cellulose TLC in solvent A (see below), was used as acceptor.
Purification Procedure. A cell-free 100,000 x g extract was prepared from 15 x 109 HeLa S3 cells that had grown to a density of S x 105 cells per ml in suspension culture (15) . After dialysis of the extract against buffer A [20 mM Hepes/KOH, pH 7.6/0.5 mM dithiothreitol/0.1 mM EDTA/10% (vol/vol) glycerol] containing 50 mM NaCl, 55 ml of packed, wet DE-52 cellulose was added and the suspension was stirred for 3 hr. Protein not retained was collected by filtration, and the cellulose cake was washed with an additional 50 ml of the buffer. The combined filtrates were applied to heparin-Sepharose, and proteins were eluted with a linear gradient of 0.05-0.45 M NaCl in buffer A. Fractions containing cyclase activity were combined as pools a and b (see Fig. lA) , and protein was precipitated by addition of (NH4)2SO4 to 75% saturation. Protein pellets were collected by ultracentrifugation, dissolved in buffer A containing 0.1 M NaCl, and dialyzed against the same. The retentates were fractionated on Sephacryl S-200 ( Fig. 1 (14) . The resulting (Ap)nAKCP was converted to (Ap)nA* by treatment with phosphatase, followed by periodate oxidation and 8-elimination as described (17) . The (21) . Nuclease P1-resistant products were analyzed for net charge by DEAE-Sephadex chromatography (22) . RESULTS RNA 3'-terminal phosphate cyclase was partially purified from HeLa cell extract by ion-exchange chromatography and gel filtration. Two peaks of cyclase activity, a and b, consistently were eluted from heparin-Sepharose at -0.26 and 0.33 M NaCl ( (Table 1 ) was applied to heparin-Sepharose (Pharmacia, 1.5 x 20 cm column) equilibrated with buffer A containing 0.1 M NaCl. After washing with 50 ml of buffer, proteins were eluted with 300 ml of a NaCl linear gradient made in buffer A. Fractions of 5 ml collected at 15 ml/hr were combined to give pools a and b. (B and C) After (NH4)2SO4 precipitation, pools a (B) and b (C) were applied to Sephacryl S-200 (Pharmacia, 1.5 x 86 cm column) equilibrated with buffer A plus 0.1 M NaCl. Fractions of 1.85 ml were collected at 7.4 ml/hr. As reported previously for a crude cyclase preparation (1) ATP stimulated cyclization of the 3'-phosphate of (Ap),A; 10-to 20-fold ( Table 2 ). The a,3-and P,y-methylene ( Chromatographic mobilities of nuclease P1-resistant products formed in the presence of ATP (Fig. 2, lanes 1 and 10) are consistent with the structures XC2(3')pp(5')A and pdC(3')pp(5')A. To (lanes 1-8) or on PEI-cellulose plates in solvent C. Trailing in lanes 3 and 7 is due to glycerol in the enzyme preparation.
grating nuclease P1-resistant compounds were isolated from TLCyplates and characterized further. Digestion of presumptive pCmppA with calf intestine phosphatase yielded radioactive Pi (Fig. 3A, lanes 2 and 6) , and treatment with tobacco acid pyrophosphatase (lanes 3 and 7) or snake venom phosphodiesterase (lanes 4 and 8) generated material comigrating with pCmp. Analysis of activated 2'-deoxy product gave analogous results (Fig. 3A, lanes 9-12) . Both activated compounds had a net charge close to -4 that was decreased 1 unit by P-elimination, in agreement with conversion of pCmppA and NdCppA (-4) to pcmpp and NdCpp (-5) , respectively (data not shown). Products of P-elimination of presumptive XCmppA and pdCppA were also analyzed by cellulose TLC. They migrated as expected for pcmpp and NdCpp; i.e., slower in solvent A and slightly faster in solvent B relative to pCmp (Fig. 3A, lanes 13-16; and data not shown). In addition, (Ap)nApCmp was incubated with T4 RNA ligase and ATP under conditions expected to generate the modified oligonucleotide, (Ap)nAfCm(3')pp(5')A (19) . Nuclease P1 digestion of the reaction product yielded a compound that comigrated with material generated in the cyclase-catalyzed reaction (Fig.  3B) .
Unlabeled (Ap)nApCmp and (Ap)nApdCp were also incubated with cyclase in the presence of [a-3 P]ATP, and the 32P-labeled oligonucleotide products were analyzed. Digestion of each oligonucleotide with nuclease P1 yielded a single radioactive spot that comigrated with the respective nuclease P1-resistant compound obtained after activation of (Ap).AfCmp and (Ap)nANdCp (not shown). These spots were identified as pCmppA and pdCppA as follows. Treatment with snake venom phosphodiesterase (Fig. 3C, lanes  2, 6, and 10 Fig. 1 B and C) . In each case the intensity of labeling coincided exactly with the profile of cyclase activity, strongly suggesting that the adenylylated protein corresponds to the RNA 3'-terminal phosphate cyclase. Presumably, changes in conformation account for the difference in apparent Mr of native enzyme (=25,000) compared to that of denatured, presumptive adenylylated cyclase (=40,000).
The activation products of (Ap).ApdCp obtained with ATP, CTP, and UTP also were analyzed. Radiolabeled dinucleotides released by nuclease P1 digestion were subjected to two-dimensional electrophoresis/homochromatography before and after digestion with snake venom phosphodiesterase. In each case phosphodiesterase treatment yielded radioactive pdCp, and the mobility shifts were diagnostic for removal of pA (not shown), pC (Fig. 4A) , and pU (Fig. 4B) , respectively. It is therefore likely that the partially purified cyclase preparation can use CTP and UTP, although less efficiently than ATP, for activation of 2'-deoxy and 2'-0-methyl substrates.
DISCUSSION
We have partially purified RNA 3'-terminal phosphate cyclase from HeLa cells, using as a convenient assay the 9 9
Biochemistry: Fflipowicz et al. (Ap)nApdCp was incubated with cyclase and 1 mM CTP (A) or UTP (B). Aliquots of nuclease P1-resistant, activated dinucleotides isolated from cellulose TLC plates as in Fig. 2 Possibly the former is due to structural differences between the analogs and ATP or to a requirement for P3,y-linkage hydrolysis during enzyme activation.
Activation of the 3'-terminal phosphate in RNA by cyclase is very similar to the reactions catalyzed by T4 (reviewed in ref. 23 ) and eukaryotic RNA ligases (4, 7) which produce A(5')pp (5' )N structures at the 5' end of RNA. With all these enzymes, transfer of the adenylyl group from ATP to RNA occurs via formation of a covalent AMP-protein intermediate (4, 23) . T4 RNA ligase can also activate the 3'-phosphorylated ends of oligodeoxynucleotides (19) by reactions that closely resemble those catalyzed by the RNA 3'-terminal phosphate cyclase from HeLa cells. With the HeLa cyclase preparations, low levels of cytidylylation and uridylylation of substrates containing terminal 2'-deoxy-or 2'-O-methylribose have also been observed. However, further studies will be necessary to determine whether these reactions are catalyzed by cyclase or by other HeLa cell proteins.
